SCHEMBL734188

SCHEMBL734188

CCOC(=O)Cn1ncc2c1CCCC2N(C)S(=O)(=O)c1ccc(Oc2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.38
SCN9A Q15858 2/20 0.37
MAPK14 Q16539 1/20 0.35
PSEN1 P49768 6/20 0.34
PSEN2 P49810 6/20 0.34
APH1B Q8WW43 6/20 0.34
NCSTN Q92542 6/20 0.34
APH1A Q96BI3 6/20 0.34
PSENEN Q9NZ42 6/20 0.34
ADRB2 P07550 1/20 0.33
AHCY P23526 2/20 0.33
LMNA P02545 1/20 0.33
CNR1 P21554 1/20 0.33
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPT P10636 1/20 0.32
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734187 1.00 F10 (0.38) F10SCN9AMAPK14PSEN1PSEN2
SCHEMBL4572478 0.94 F10 (0.38) F10MAPK14PSEN1PSEN2APH1B
SCHEMBL734020 0.93 F10 (0.37) F10SCN9AMAPK14PSEN1PSEN2
SCHEMBL734021 0.93 F10 (0.37) F10SCN9AMAPK14PSEN1PSEN2
SCHEMBL733663 0.91 F10 (0.41) F10SCN9AMAPK14PSEN1PSEN2
SCHEMBL733664 0.91 F10 (0.41) F10SCN9AMAPK14PSEN1PSEN2
SCHEMBL2138929 0.91 F10 (0.35) F10MAPK14AHCYCNR1ALDH1A1
SCHEMBL752889 0.91 F10 (0.35) F10MAPK14AHCYCNR1ALDH1A1
SCHEMBL734161 0.91 SCN9A (0.38) F10SCN9APSEN1PSEN2APH1B
SCHEMBL734160 0.91 SCN9A (0.38) F10SCN9APSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420675-B2 Aminotetrahydroindazoloacetic acids HOFFMANN-LA ROCHE INC. (US) 2013-04-16 US disclosed
EP-2307383-B1 AMINOTETRAHYDROINDAZOLOACETIC ACIDS HOFFMANN LA ROCHE (CH) 2012-05-16 EP disclosed
US-20120101131-A1 Aminotetrahydroindazoloacetic Acids CHEN LI (CN) 2012-04-26 US disclosed
US-8138208-B2 Aminotetrahydroindazoloacetic acids HOFFMANN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100016369-A1 AMINOTETRAHYDROINDAZOLOACETIC ACIDS CHEN LI 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101131-A1 Aminotetrahydroindazoloacetic Acids HRH2, HRH1, HRH4 F10 736/4885SCN9A 2017/4885MAPK14 3949/4885
US-20100016369-A1 AMINOTETRAHYDROINDAZOLOACETIC ACIDS HRH2, HRH1, HRH4 F10 736/4885SCN9A 2017/4885MAPK14 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.